Skip to content
PIL Logo

Invirase 500mg Film-coated Tablets

Last Updated on eMC 07-Dec-2016 View document  | Roche Products Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07-Dec-2016 and displayed until Current

Reasons for adding or updating:

  • Change to section 1 - what the product is
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 04-Mar-2016 and displayed until 07-Dec-2016

Reasons for adding or updating:

  • Change to section 4 - how to report a side effect

Updated on 26-Feb-2016 and displayed until 04-Mar-2016

Reasons for adding or updating:

  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - date of revision

Updated on 07-Jan-2016 and displayed until 26-Feb-2016

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 07-May-2014 and displayed until 07-Jan-2016

Reasons for adding or updating:

  • Change to section 6 - date of revision
  • Removal of black triangle

Updated on 17-Apr-2014 and displayed until 07-May-2014

Reasons for adding or updating:

  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 25-Oct-2013 and displayed until 17-Apr-2014

Reasons for adding or updating:

  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision

Updated on 28-Aug-2013 and displayed until 25-Oct-2013

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision
  • Change to other sources of information section

Updated on 05-Jul-2013 and displayed until 28-Aug-2013

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - date of revision

Updated on 15-Feb-2013 and displayed until 05-Jul-2013

Reasons for adding or updating:

  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
  • Correction of spelling/typing errors

Updated on 31-Oct-2012 and displayed until 15-Feb-2013

Reasons for adding or updating:

  • Correction of spelling/typing errors
  • Change to drug interactions

Updated on 05-Jul-2012 and displayed until 31-Oct-2012

Reasons for adding or updating:

  • Change to date of revision
  • Change to drug interactions
  • Extra statutory information

Updated on 01-May-2012 and displayed until 05-Jul-2012

Reasons for adding or updating:

  • Correction of spelling/typing errors

Updated on 12-Apr-2012 and displayed until 01-May-2012

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to drug interactions
  • Change to dosage and administration

Updated on 11-Jan-2011 and displayed until 12-Apr-2012

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change to dosage and administration

Updated on 05-Aug-2010 and displayed until 11-Jan-2011

Reasons for adding or updating:

  • Change to warnings or special precautions for use

Updated on 01-Apr-2010 and displayed until 05-Aug-2010

Reasons for adding or updating:

  • Change to Further Information section

Updated on 25-Mar-2010 and displayed until 01-Apr-2010

Reasons for adding or updating:

  • Change to drug interactions

Updated on 09-Apr-2009 and displayed until 25-Mar-2010

Reasons for adding or updating:

  • Change to warnings or special precautions for use

Updated on 24-Mar-2009 and displayed until 09-Apr-2009

Reasons for adding or updating:

  • Correction of spelling/typing errors

Updated on 13-Feb-2009 and displayed until 24-Mar-2009

Reasons for adding or updating:

  • Correction of spelling/typing errors

Updated on 22-Jul-2008 and displayed until 13-Feb-2009

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change to side-effects

Updated on 06-Dec-2007 and displayed until 22-Jul-2008

Reasons for adding or updating:

  • Correction of spelling/typing errors

Updated on 06-Nov-2007 and displayed until 06-Dec-2007

Reasons for adding or updating:

  • Change to drug interactions

Updated on 08-Jun-2007 and displayed until 06-Nov-2007

Reasons for adding or updating:

  • Change to date of revision

Updated on 13-Apr-2007 and displayed until 08-Jun-2007

Reasons for adding or updating:

  • Change to side-effects
  • Change to date of revision

Updated on 22-Jan-2007 and displayed until 13-Apr-2007

Reasons for adding or updating:

  • Change to warnings or special precautions for use

Updated on 16-Jan-2007 and displayed until 22-Jan-2007

Reasons for adding or updating:

  • Change to Further Information section

Updated on 05-Dec-2006 and displayed until 16-Jan-2007

Reasons for adding or updating:

  • Change to date of revision

Updated on 01-Nov-2006 and displayed until 05-Dec-2006

Reasons for adding or updating:

  • Change to drug interactions
  • Change to date of revision

Updated on 31-Oct-2006 and displayed until 01-Nov-2006

Reasons for adding or updating:

  • Change to drug interactions

Updated on 16-Jan-2006 and displayed until 31-Oct-2006

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change to date of revision
  • Change from BAN to rINN

Updated on 12-Sep-2005 and displayed until 16-Jan-2006

Reasons for adding or updating:

  • Change to drug interactions
  • Change to date of revision

Updated on 07-Jul-2005 and displayed until 12-Sep-2005

Reasons for adding or updating:

  • Change of contra-indications

Updated on 31-May-2005 and displayed until 07-Jul-2005

Reasons for adding or updating:

  • New PIL for new product

Company contact details

Roche Products Limited

Company image
Address

Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW

Fax

+44 (0)1707 338 297

Medical Information e-mail
Medical Information Fax

+44 (0)1707 384555

Telephone

+44 (0)1707 366 000

Medical Information Direct Line

+44 (0)800 328 1629

Customer Care direct line

+44 (0)800 731 5711

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

saquinavir mesilate

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue